Trial design
The trial was a single-center, CONSORT-compliant, patient-blinded, 2-group, parallel randomized controlled trial (RCT) conducted in September 2020 as demonstrated in Fig.  CONSORT flow diagram depicting participant flow throughout the study, from eligibility through enrollment, intervention, and data collection